数位治疗市场规模、份额、成长分析（按产品、应用、收益模式、销售管道和地区）—2025 年至 2032 年产业预测

2023 年数位治疗市场规模价值 65 亿美元，预计将从 2024 年的 82.1 亿美元成长到 2032 年的 531.5 亿美元，预测期间（2025-2032 年）的复合年增长率为 26.3%。

数位治疗市场正在经历强劲成长，这得益于对提供循证治疗性介入的软体和设备的需求激增。这些技术将帮助医疗保健提供者预防和管理一系列慢性疾病，包括精神健康障碍、糖尿病、呼吸系统疾病和心血管疾病。糖尿病、精神疾病、癌症和心臟衰竭等慢性疾病的盛行率不断上升，大大推动了市场采用。此外，製药业对数位疗法的采用日益增多，进一步推动了这一势头。行业领导者正在优先考虑研发，以创新先进的治疗方法并进一步推动产品开发。这些因素共同促进了数位治疗市场的成长，扩大了患者的治疗选择。

目录

介绍

• 调查目的
• 研究范围
• 定义

调查方法

• 资讯采购
• 二次资料和一次资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分机会分析

市场动态与展望

• 市场概览
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特的分析

关键市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2024年）
• PESTEL分析
• 总体经济指标
• 价值链分析
• 专利分析
• 技术分析
• 案例研究

数位治疗市场规模（按产品和复合年增长率） (2025-2032)

• 市场概览
• 软体/平台
• 程式
• 虚拟实境/游戏

数位治疗市场规模（按应用划分）及复合年增长率（2025-2032）

• 市场概览
• 治疗/护理相关应用
  • 糖尿病
  • 中枢神经系统 (CNS) 疾病
  • 精神疾病
  • 其他中枢神经系统疾病
  • 禁止抽烟
  • 慢性呼吸系统疾病
  • 肌肉骨骼疾病
  • 心血管疾病
  • 药物依从性
  • 胃肠道疾病
  • 復健和患者照护
  • 物质使用疾患与成瘾管理
  • 其他治疗/护理相关用途
• 预防性使用
  • 糖尿病前期
  • 肥胖
  • 营养
  • 生活方式管理
  • 其他预防应用

数位治疗市场规模（按收益模式和复合年增长率） (2025-2032)

• 市场概览
• 订阅模式
• 一次性购买/年度授权模式
• 基于结果/价值的模型

数位治疗市场规模（按销售管道和复合年增长率） (2025-2032)

• 市场概览
• B2B销售管道
  • 付款人
  • 雇主
  • 製药公司
  • 提供者
  • 其他买家
• B2C销售管道
  • 看护者
  • 病人

数位治疗市场规模（按地区）及复合年增长率（2025-2032）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业市场定位（2024年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市场占有率分析（2024年）
• 主要企业简介
  • 公司详情
  • 产品系列分析
  • 公司分部份额分析
  • 收益与前一年同期比较对比（2022-2024 年）

主要企业简介

• Dassault Systemes（SIMULIA）（France）
• Siemens Digital Industries Software（Simcenter）（Germany）
• PTC（Creo）（US）
• Autodesk（Simulation）（US）
• OpenFOAM（Open-source）（N/A）
• STAR-CCM+（US/Germany）
• COMSOL Multiphysics（Sweden）
• ESI Group（France）
• MathWorks（MATLAB/Simulink）（US）
• Flow3D（US）
• Cadence Design Systems（US）
• Synopsys（US）
• Pointwise（US）

结论和建议

Digital Therapeutics Market size was valued at USD 6.5 billion in 2023 and is poised to grow from USD 8.21 billion in 2024 to USD 53.15 billion by 2032, growing at a CAGR of 26.3% during the forecast period (2025-2032).

The digital therapeutics market is experiencing robust growth, driven by a surge in demand for software and devices that offer evidence-based therapeutic interventions. These technologies assist healthcare providers in the prevention and management of various chronic diseases, including mental health disorders, diabetes, respiratory conditions, and cardiovascular issues. Rising incidences of chronic illnesses such as diabetes, mental health disorders, cancer, and heart failure are significantly boosting market adoption. Additionally, the pharmaceutical sector's increasing embrace of digital therapeutics is contributing to this momentum. Industry leaders are prioritizing research and development to innovate advanced therapies, further propelling product development. Collectively, these elements are fostering the expansion of the digital therapeutics market and enhancing treatment options for patients.

Top-down and bottom-up approaches were used to estimate and validate the size of the Digital Therapeutics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Digital Therapeutics Market Segments Analysis

Global Digital Therapeutics Market is segmented by Offering, Application, Revenue Model, Sales Channel and region. Based on Offering, the market is segmented into Software/Platforms, Programs and Virtual Reality/Games. Based on Application, the market is segmented into Treatment/Care-Related Applications and Preventive Applications. Based on Revenue Model, the market is segmented into Subscription-Based Model, One-Time Purchase/Annual Licensing Model and Outcome /Value-Based Model. Based on Sales Channel, the market is segmented into B2B Sales Channel and B2C Sales Channel. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Digital Therapeutics Market

The Digital Therapeutics market is being significantly driven by the rising demand for software and devices aimed at managing and treating chronic diseases worldwide. With a growing prevalence of chronic conditions, including type 1 and type 2 diabetes, various cancers, Alzheimer's disease, obesity, and gastrointestinal disorders, the need for innovative therapeutic solutions is becoming increasingly critical. This trend is particularly notable in emerging economies, where the demand for effective digital health interventions is surging. As more people seek accessible and efficient management options for these chronic conditions, the digital therapeutics sector is poised for substantial growth throughout the forecast period.

Restraints in the Digital Therapeutics Market

The Digital Therapeutics market, characterized by its innovative software and device-driven products designed to prevent, manage, or treat various medical conditions, faces significant challenges that hinder its growth. Increasing concerns over cybersecurity threaten to impede the widespread adoption of these therapeutics, as patients grow increasingly aware of the potential risks to their personal medical data. Additionally, regulatory uncertainties, complications with reimbursement processes, and unequal access to technology further complicate the landscape, limiting the market's expansion. As these issues continue to unfold, they contribute to a restrained environment for digital therapeutics in the healthcare ecosystem.

Market Trends of the Digital Therapeutics Market

The integration of digital therapeutics with healthcare systems marks a significant trend in the market, reflecting a shift towards more accessible and efficient patient care. By seamlessly connecting digital therapeutic solutions with electronic health records (EHRs) and other healthcare platforms, providers can enhance real-time data access and monitoring capabilities, ultimately facilitating informed clinical decision-making. This integration not only boosts operational efficiencies and patient outcomes but also strengthens data security and standardization in information sharing. As healthcare continues to embrace technology, the demand for digital therapeutics that align with existing healthcare infrastructures is poised to grow, driving innovation and investment in this pivotal sector.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Patent Analysis
• Technology Analysis
• Case Studies

Global Digital Therapeutics Market Size by Offering & CAGR (2025-2032)

• Market Overview
• Software/Platforms
• Programs
• Virtual Reality/Games

Global Digital Therapeutics Market Size by Application & CAGR (2025-2032)

• Market Overview
• Treatment/Care-Related Applications
  • Diabetes
  • Central Nervous System (CNS) Disorders
  • Mental health disorders
  • Other CNS disorders
  • Smoking Cessation
  • Chronic Respiratory Diseases
  • Musculoskeletal Disorders
  • Cardiovascular Diseases
  • Medication Adherence
  • Gastrointestinal Disorders
  • Rehabilitation & Patient Care
  • Substance Use Disorders & Addiction Management
  • Other Treatment/Care-Related Applications
• Preventive Applications
  • Prediabetes
  • Obesity
  • Nutrition
  • Lifestyle Management
  • Other Preventive Applications

Global Digital Therapeutics Market Size by Revenue Model & CAGR (2025-2032)

• Market Overview
• Subscription-Based Model
• One-Time Purchase/Annual Licensing Model
• Outcome /Value-Based Model

Global Digital Therapeutics Market Size by Sales Channel & CAGR (2025-2032)

• Market Overview
• B2B Sales Channel
  • Payers
  • Employers
  • Pharmaceutical Companies
  • Providers
  • Other Buyers
• B2C Sales Channel
  • Caregivers
  • Patients

Global Digital Therapeutics Market Size & CAGR (2025-2032)

• North America (Offering, Application, Revenue Model, Sales Channel)
  • US
  • Canada
• Europe (Offering, Application, Revenue Model, Sales Channel)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Offering, Application, Revenue Model, Sales Channel)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Offering, Application, Revenue Model, Sales Channel)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Offering, Application, Revenue Model, Sales Channel)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Dassault Systemes (SIMULIA) (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Digital Industries Software (Simcenter) (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PTC (Creo) (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Autodesk (Simulation) (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• OpenFOAM (Open-source) (N/A)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• STAR-CCM+ (US/Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• COMSOL Multiphysics (Sweden)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ESI Group (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MathWorks (MATLAB/Simulink) (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Flow3D (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cadence Design Systems (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Synopsys (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pointwise (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations